Source: Annual Congress 2007 - Cystic fibrosis: better diagnosis, improved progress, but long-term complications



Rating:

Share or cite this content

Citations should be made in the following way:
K. Mohan, S. Huda, M. Ledson, M. Walshaw (Liverpool, United Kingdom). Prevalence of hyperglycaemia during infective exacerbation in adult cystic fibrosis patients. Eur Respir J 2007; 30: Suppl. 51, 2298

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of acute liver dysfunction and chronic liver disease in an Irish adult cystic fibrosis population Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Viral infections trigger exacerbations of cystic fibrosis in adults and children Source: Eur Respir J 2012; 40: 510-512 Year: 2012 Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Identifying undiagnosed cystic fibrosis in adults with bronchiectasis Source: Eur Respir Monogr 2018; 81: 29-44 Year: 2018 Prevalence of tracheobronchomalacia in young children with cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease in China Source: International Congress 2017 – COPD biomarkers Year: 2017 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Prevalence of adrenal insufficiency in patients started on Mepolizumab for severe eosinophilic asthma. Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019 Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009